Abstract
A 69-year-old woman who presented with left lower quadrant abdominal pain and elevated serum cancer antigen 125 (CA-125) levels was referred for an MRI and an 18F-FDG PET/CT to evaluate a suspicious abdominal mass seen on ultrasound. PET/CT showed extensive, intensely FDG-avid, omental and pelvic peritoneal thickening with no suspicious ovarian or colon masses. Based on the PET/CT results, the patient had extensive debulking surgery and histopathological evaluation revealed an extraovarian primary peritoneal carcinoma (EOPPC). 18F-FDG PET/CT may be useful in differentiating EOPPC from other types of peritoneal carcinomatosis, and in determining the extent of the disease to better guide surgical management and improve long term outcomes.
References
Bhuyan P, Mahapatra S, Mahapatra S, et al. (2010) Extraovarian primary peritoneal papillary serous carcinoma. Arch Gynecol Obstet 281:561–564
Turlakow A, Yeung HW, Salmon AS, Macapinlac HA, Larson SM (2003) Peritoneal carcinomatosis: role of 18F-FDG PET. J Nucl Med 44:1407–1412
Wang PH, Liu RS, Li YF, Ng HT, Yuan CC (2000) Whole-body PET with (fluorine-18)-2-deoxyglucose for detecting recurrent primary serous peritoneal carcinoma: An initial report. Gynecol Oncol 77:44–47
Rose PG, Faulhaber P, Miraldi F, Abdul-Karim FW (2001) Positive emission tomography for evaluating a complete clinical response in patients with ovarian or peritoneal carcinoma: correlation with second-look laparotomy. Gynecol Oncol 82:17–21
Eltabbakh GH, Werness BA, Piver S, Blumenson LE (1998) Prognostic factors in extraovarian primary peritoneal carcinoma. Gynecol Oncol 71:230–239
Grant DJ, Moorman PG, Akushevich L, et al. (2010) Primary peritoneal and ovarian cancers: an epidemiological comparative analysis. Cancer Causes Control 21:991–998
Goodman MT, Shvetsov YB (2009) Rapidly increasing incidence of papillary serous carcinoma of the peritoneum in the United States: fact or artifact? Int J Cancer 124:2231–2235
Muto MG, Welch WR, Mok SC, et al. (1995) Evidence for a multifocal origin of papillary serous carcinoma of the peritoneum. Cancer Res 55:490–492
White CD (1993) Papillary intraperitoneal neoplasia resembling ovarian carcinoma after removal of benign ovaries. W V Med J 89:282–283
Shmueli E (2001) Primary papillary serous carcinoma of the peritoneum in a man. Ann Oncol 12:563–567
Shibata R (2004) Extraovarian primary peritoneal carcinoma in a child. Pediatr Blood Cancer 42:292–293
Levine DA, Argenta PA, Yee CJ, et al. (2003) Fallopian tube and primary peritoneal carcinomas associated with BRCA mutations. J Clin Oncol 21:4222–4227
Fromm GL (1990) Papillary serous carcinoma of the peritoneum. Obstet Gynaecol 75:75–89
Eltabbakh GH, Piver MS, Natarajan N, Mettlin CJ (1998) Epidemiologic differences between women with extraovarian primary peritoneal carcinoma and women with epithelial ovarian cancer. Obstet Gynaecol 91:254–259
Dalrymple JC, Bannatyne P, Russell P, et al. (1989) Extraovarian peritoneal serous papillary carcinoma: a clinicopathologic study of 31 cases. Cancer 64:110–115
Alvarez JV, Gomez MM, Prats MDG, et al. (2007) Extraovarian primary peritoneal carcinoma: a case report. Rev Esp Patol 40:47–52
Levy AD, Arnaiz J, Shaw JC, Sobin LH (2008) Primary peritoneal tumors: imaging features with pathologic correlation. Radiographics 28:583–607
Stafford-Johnson DB, Bree RL, Francis IR, Korobkin M (1998) CT appearance of primary papillary serous carcinoma of the peritoneum. AJR Am J Roentgenol 171:687–689
Chopra S, Laurie LR, Chintapalli KN, et al. (2000) Primary papillary serous carcinoma of the peritoneum: CT-pathologic correlation. J Comput Assist Tomogr 24:395–399
Gryspeerdt S, Clabout L, Van Hoe L, Berteloot P, Vergote IB (1998) Intraperitoneal contrast material combined with CT for detection of peritoneal metastases of ovarian cancer. Eur J Gynaecol Oncol 19:434–437
Raptopoulos V, Gourtsoyiannis N (2001) Peritoneal carcinomatosis. Eur Radiol 11:2195–2206
Low RN (1997) Peritoneal tumor: MR imaging with dilute oral barium and intravenous gadolinium containing contrast agents compared with unenhanced MR imaging and CT. Radiology 204:513–520
Ricke J, Sehoule J, Hosten N, et al. (1999) Fat-saturated, contrast-enhanced spin-echo sequences in the magnetic resonance tomographic diagnosis of peritoneal carcinosis [in German]. Rofo 171:461–467
Choi CH, Kim TJ, Kim WY, et al. (2007) Papillary serous carcinoma in ovaries of normal size: a clinicopathologic study of 20 cases and comparison with extraovarian peritoneal papillary serous carcinoma. Gynecol Oncol 105:762–768
Dirisamer A, Schima W, Heinisch M, et al. (2009) Detection of histologically proven peritoneal carcinomatosis with fused 18F-FDG PET/MDCT. Eur J Radiol 69:536–541
De Gaetano AM, Calcagni ML, Rufini V, et al. (2009) Imaging of peritoneal carcinomatosis with FDG PET-CT: diagnostic patterns, case examples and pitfalls. Abdom Imag 34:391–402
Dromain C, Leboulleux S, Auperin A, et al. (2008) Staging of peritoneal carcinomatosis: enhanced CT vs PET/CT. Abdom Imag 33:87–93
Suzuki A, Kawano T, Takahashi N, et al. (2004) Value of 18F-FDG PET in the detection of peritoneal carcinomatosis. Eur J Nucl Med Mol Imag 31:1413–1420
Kim CK, Park BK, Choi JY, Kim JH (2009) Comparison of the MRI and integrated PET/CT findings in the preoperative detection of peritoneal carcinomatosis arising from primary ovarian cancer. J Korean Soc Radiol 60:117–126
Funicelli L, Travaini LL, Landoni F, et al. (2010) Peritoneal carcinomatosis from ovarian cancer: the role of CT and [(18F)]FDG-PET/CT. Abdom Imag 35:701–707
Lloyd GM, Neal CP, Da Forno PD, West K, Miller AS (2010) Metastatic primary peritoneal carcinoma: an unexpected finding on histological examination of haemorrhoids. Colorectal Dis 12:602–603
Eltabbakh GH, Piver MS, Hempling RE, Werness BA, Blumenson LE (1998) Importance of lymph node metastases in primary peritoneal carcinoma. J Surg Oncol 68:144–148
Eltabbakh GH, Piver MS, Werness BA (1997) Primary peritoneal adenocarcinoma metastatic to the brain. Gynecol Oncol 66:160–163
Piver MS, Eltabbakh GH, Hempling RE, Recio FO, Blumenson LE (1997) Two sequential studies for primary peritoneal carcinoma: induction with weekly cisplatin followed by either cisplatin-doxorubicin-cyclophosphamide or paclitaxel-cisplatin. Gynecol Oncol 67:141–146
Gunn AJ, Brechbiel MW, Choyke PL (2007) The emerging role of molecular imaging and targeted therapeutics in peritoneal carcinomatosis. Expert Opin Drug Deliv 4:389–402
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Rakheja, R., Makis, W. & Hickeson, M. Extraovarian primary peritoneal carcinoma: staging with 18F-FDG PET/CT. Abdom Imaging 37, 304–308 (2012). https://doi.org/10.1007/s00261-011-9722-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00261-011-9722-0